I’m pleased to share my professional biography and a reflection on a career that has taken me from nursing and cardiovascular research to clinical and executive leadership in the medical device industry. Throughout that journey, I’ve had the opportunity to lead clinical strategies, pivotal trials, global teams, regulatory initiatives, and board and community efforts, always guided by a desire to keep growing, keep learning, and contribute where my experience can make a meaningful difference. As I continue exploring board and advisory opportunities, I look forward to bringing that experience, curiosity, and perspective to organizations navigating their next stage of growth.

Clinical expertise is often the missing ingredient in healthcare, education, and age tech innovation. Drawing on more than two decades as a Speech-Language Pathologist and seven years collaborating with Google, startups, and research institutions, Katie Seaver explains why involving clinicians at the earliest stages of product development leads to smarter research, more practical solutions, and stronger user adoption. This article explores how bridging clinical insight with technology innovation creates products that truly serve the people they are designed to help, transforming accessibility and impact through a more strategic, human-centered approach.

Dr. Trudy Vanhove is a seasoned biopharmaceutical executive and venture partner with nearly 30 years of experience leading drug development, regulatory strategy, and corporate growth across biotech and pharmaceutical companies. She has played a pivotal role in launching multiple FDA- and EMA-approved therapies and has a strong track record in building high-performing teams, driving strategic partnerships, and supporting financing efforts. Fluent in several languages and with extensive international experience, Dr. Vanhove brings a unique global perspective and a deep scientific and business acumen to board roles and investment opportunities in the biotech sector.